Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
10th week of 2021 patent applcation highlights part 9
Patent application number
Title
Published
20210069130
USE OF METFORMIN SALT IN THE TREATMENT OF CEREBRAL INFARCTION
2021-03-11
20210069131
TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
2021-03-11
20210069132
TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
2021-03-11
20210069133
TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
2021-03-11
20210069134
COMPOSITIONS AND METHODS OF TREATING A SUBJECT WITH TAURINE AND DERIVATIVES THEREOF
2021-03-11
20210069135
THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
2021-03-11
20210069136
GHB PHARMACEUTICAL COMPOSITIONS COMPRISING A FLOATING INTERPENETRATING POLYMER NETWORK FORMING SYSTEM
2021-03-11
20210069137
TRANSDERMAL ANALGESIC FORMULATION
2021-03-11
20210069138
PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT
2021-03-11
20210069139
STABILIZATION OF TRANSTHYRETIN TETRAMERS IN BIOLOGICAL FLUIDS
2021-03-11
20210069140
TREATMENT OF DISEASE WITH N-ACETYL KYNURENINE
2021-03-11
20210069141
ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID
2021-03-11
20210069142
METHODS OF TREATING HYPERTRIGLYCERIDEMIA
2021-03-11
20210069143
LOW-ALCOHOL ANTIMICROBIAL COMPOSITION AND USE THEREOF
2021-03-11
20210069144
ISOTOPICALLY MODIFIED COMPOSITION AND THERAPEUTIC USES THEREOF
2021-03-11
20210069145
COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF
2021-03-11
20210069146
Recognition ability improving agent
2021-03-11
20210069147
PHARMACEUTICAL COMBINATION AND USES THEREOF
2021-03-11
20210069148
GINGKO DITERPENE LACTONE COMPOSITION
2021-03-11
20210069149
METHOD FOR ADMINISTRATION
2021-03-11
20210069150
MODIFIED RELEASE FORMULATION
2021-03-11
20210069151
SYNERGISTIC PHARMACEUTICAL COMBINATION OF THE ACTIVE ENANTIOMER S-KETOROLAC TROMETHAMINE AND TRAMADOL CHLORHYDRATE
2021-03-11
20210069152
METHODS FOR TREATING HETEROTOPIC OSSIFICATION
2021-03-11
20210069153
ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME
2021-03-11
20210069154
Treatment of Breast Cancer
2021-03-11
20210069155
SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
2021-03-11
20210069156
THERANOSTIC TEST FOR ANTIFUNGAL TREATMENT OF INFLAMMATORY DISEASES
2021-03-11
20210069157
AGENT FOR TREATMENT OF PBC
2021-03-11
20210069158
Methods of Preventing Occurrence of Cardiovascular Events
2021-03-11
20210069159
Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof
2021-03-11
20210069160
DOSAGE REGIMEN FOR PICOTAMIDE FOR THE USE IN MIGRAINE
2021-03-11
20210069161
Methods Of Treating Fabry Patients Having Renal Impairment
2021-03-11
20210069162
Methods Of Treating Fabry Patients Having Renal Impairment
2021-03-11
20210069163
ANTICANCER COMBINATION OF CHIDAMIDE AND CELECOXIB SALTS
2021-03-11
20210069164
Compositions and Methods for Treatment of Edema
2021-03-11
20210069165
AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF
2021-03-11
20210069166
Combination Therapy
2021-03-11
20210069167
COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
2021-03-11
20210069169
PHARMACEUTICAL COMPOSITIONS
2021-03-11
20210069170
TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH
2021-03-11
20210069172
METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION
2021-03-11
20210069173
PREPARATION OF (-)-COCAINE HYDROCHLORIDE
2021-03-11
20210069174
COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS
2021-03-11
20210069175
Compositions and Methods for Identifying and Treating Dystonia Disorders
2021-03-11
20210069176
Treating Autoimmune Disorders with Chloroquine and/or Hydroxychloroquine
2021-03-11
20210069177
METHOD FOR DESTROYING CELLULAR MECHANICAL HOMEOSTASIS AND PROMOTING REGENERATION AND REPAIR OF TISSUES AND ORGANS, AND USE THEREOF
2021-03-11
20210069178
Method for Inducing a Sustained Immune Response
2021-03-11
20210069179
TREATMENT OF DEMYELINATING DISEASES
2021-03-11
20210069180
METHODS FOR TREATING CHRONIC FATIGUE SYNDROME AND MYALGIC ENCEPHALOMYELITIS
2021-03-11
20210069181
Compositions And Methods For Reducing Major Adverse Cardiovascular Events
2021-03-11
20210069182
ROR-GAMMA MODULATORS
2021-03-11
20210069183
COMPOSITION CONTAINING PIPERACILLIN, PHARMACEUTICAL FORMULATION THEREOF AND USE THEREOF
2021-03-11
20210069184
METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY
2021-03-11
20210069185
USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY
2021-03-11
20210069186
METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
2021-03-11
20210069187
Stable pharmaceutical composition of Selexipag
2021-03-11
20210069188
PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
2021-03-11
20210069189
TREATMENT OF NEURODEGENERATIVE DISEASES
2021-03-11
20210069190
PHARMACEUTICAL COMPOSITION COMPRISING SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREFOR
2021-03-11
20210069191
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
2021-03-11
20210069192
USE OF NEUTROPHIL ELASTASE INHIBITORS IN LIVER DISEASE
2021-03-11
20210069193
JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
2021-03-11
20210069194
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
2021-03-11
20210069195
RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
2021-03-11
20210069196
THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND COMBINATIONS WITH ANTICANCER AGENTS
2021-03-11
20210069197
P110-DELTA INHIBITORS TREAT AND PREVENT AUTOIMMUNITY WHILE SPARING THE ABILITY TO MOUNT AN IMMUNE RESPONSE TO EXOGENOUS IMMUNOGENS
2021-03-11
20210069198
COMPOSITION CONTAINING CANNABIDIOL/CANNABIS EXTRACT AND CAFFEINE, AND APPLICATION OF COMPOSITION
2021-03-11
20210069199
METHODS OF TREATING TRANSPLANT REJECTION
2021-03-11
20210069200
COMPOSITIONS COMPRISING PHOSPHOINOSITIDE 3-KINASE INHIBITORS AND A SECOND ANTIPROLIFERATIVE AGENT
2021-03-11
20210069201
SELECTIVE P2X3 MODULATORS
2021-03-11
20210069202
METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH INHIBITION OF ATG4B
2021-03-11
20210069203
DNA-PK INHIBITORS
2021-03-11
20210069204
DOSAGE OF BALOXAVIR MARBOXIL FOR PEDIATRIC PATIENTS
2021-03-11
20210069205
BACE1 INHIBITION FOR THE TREATMENT OF CANCER
2021-03-11
20210069206
MIRTAZAPINE AS A PRE-SHIPPING INHIBITOR OF BOVINE RESPIRATORY DISEASE
2021-03-11
20210069207
PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF
2021-03-11
20210069208
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
2021-03-11
20210069209
NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MENOPAUSE RELATED ANXIETY AND DEPRESSION
2021-03-11
20210069210
VAGINAL COMPOSITION COMPRISING A COMBINATION OF ESTROGEN AND VITAMIN D
2021-03-11
20210069211
BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
2021-03-11
20210069212
ANORDRIN COMPOSITIONS AND METHODS FOR TREATING DISEASES
2021-03-11
20210069213
COMPOSITION AND METHOD OF TREATMENT FOR DRY A.M.D. (AGE RELATED MACULAR DEGENERATION)
2021-03-11
20210069214
TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID FOR THE TREATMENT OF PSORIASIS IN PEDIATRIC PATIENTS
2021-03-11
20210069215
Composition for Inhalation
2021-03-11
20210069216
COMPOSITIONS AND METHODS OF TREATING NEURONAL INJURY
2021-03-11
20210069217
INHIBITION OF LIPOFUSCIN AGGREGATION BY MOLECULAR TWEEZERS
2021-03-11
20210069218
METHODS OF CONTROLLING TUMOR BIOENERGETICS NETWORKS
2021-03-11
20210069219
Boron Containing PDE4 Inhibitors
2021-03-11
20210069220
METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS
2021-03-11
20210069221
MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BACTERIAL INFECTIONS AND RELATED SYMPTOMS
2021-03-11
20210069222
TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
2021-03-11
20210069223
USE OF COMPOUND FOR PREVENTING AND/OR TREATING OBESITY
2021-03-11
20210069224
Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
2021-03-11
20210069225
LIPONUCLEOTIDE-BASED THERAPY FOR ARDS
2021-03-11
20210069226
URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
2021-03-11
20210069227
A3 ADENOSINE RECEPTOR LIGAND FOR MANAGING CYTOKINE RELEASE SYNDROME
2021-03-11
20210069228
PHARMACEUTICAL OR COSMETIC COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH
2021-03-11
20210069229
Compositions Containing Adenosine Triphosphate (ATP) and Methods of Use
2021-03-11
20210069230
SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES
2021-03-11
20210069231
PHARMACEUTICAL CARRIERS CONTAINING miRNAs FOR USE IN THE TREATMENT OF RENAL CANCER
2021-03-11